<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">Biomed Res Int</span><span class="iso-abbrev" title="iso-abbrev">Biomed Res Int</span><span class="publisher-id" title="publisher-id">BMRI</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">BioMed Research International</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">2314-6133</span><span class="issn-epub" tagx="issn" title="issn-epub">2314-6141</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">Hindawi</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7688356">7688356</a></span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1155/2020/8872479">10.1155/2020/8872479</a></span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Research Article</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Antioxidant Activity of Telmisartanâ€"Cu(II) Nanoparticles Connected 2-Pyrimidinamine and Their Evaluation of Cytotoxicity Activities</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Surendrakumar</span><span class="given-names" tagx="given-names" title="given-names">Radhakrishnan</span></span><a href="#I1"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0003-0309-6274</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Idhayadhulla</span><span class="given-names" tagx="given-names" title="given-names">Akbar</span></span><span class="email" tagx="email" title="email">a.idhayadhulla@gmail.com</span><a href="#I1"><sup>1</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Alarifi</span><span class="given-names" tagx="given-names" title="given-names">Saud</span></span><a href="#I2"><sup>2</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ahamed</span><span class="given-names" tagx="given-names" title="given-names">Nazeer Anis</span></span><a href="#I3"><sup>3</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sathish Kumar</span><span class="given-names" tagx="given-names" title="given-names">Chidambaram</span></span><a href="#I1"><sup>1</sup></a></span></div><span class="citation_author_institution" id="I1">[], <sup>1</sup></span><span class="citation_author_institution" id="I2">[], <sup>2</sup></span><span class="citation_author_institution" id="I3">[], <sup>3</sup></span><div class="author-notes" title="author-notes"> <div class="fn-type-other" title="other"> <p>Academic Editor: Hui-Min David Wang</p> </div> </div><span class="pub-date-collection" title="pub-date-collection">collection: <span>2020</span></span><span class="pub-date-epub" title="pub-date-epub">epub: <span>2020-11-11</span></span><span class="volume" tagx="volume" title="volume">2020</span><span class="elocation-id" tagx="elocation-id" title="elocation-id">8872479</span><span class="history" title="history"><span class="received" title="received">received: 2020-9-3</span><span class="rev-recd" title="rev-recd">rev-recd: 2020-9-15</span><span class="accepted" title="accepted">accepted: 2020-10-30</span></span><div class="permissions"><span class="copyright" title="copyright">(C) , <span class="copyright-year" tagx="copyright-year" title="copyright-year">2020</span></span><span class="license" title="license"><span class="license-p" title="license-p">This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</span></span></div> <div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <p>Copper nanoparticles (Cu-Nps) are one of the promising materials for the advancement of nanoscience and technology. In this work, we synthesized telmisartan copper nanoparticles and 2-pyrimidinamines via Biginelli reaction using telmisartan copper nanoparticles (Cu-Nps) as a reusable catalyst. The synthesis of 2-pyrimidinamine derivatives (1a-c) was achieved in water and under solvent-free condition (Green chemistry approach). Synthesis of 2-pyrimidinamine with telmisartan copper nanoparticle (Cu-Npsâ€"Pyr) unexpected product was also isolated from synthesis of 2-pyrimidinamine preparation. Antioxidant and cytotoxic activities were carried out both in 2-pyrimidinamine (1a-1c) and 2-pyrimidinamine with telmisartan copper nanoparticles (Cu-Npsâ€"Pyr). The synthesized 2-pyrimidinamine derivatives (1a-c) were characterized from FT-IR, <sup>1</sup>H and <sup>13</sup>C NMR spectroscopy, mass and elemental analyses. The synthesized telmisartan copper nanoparticles (Cu-Nps) were characterized from UV spectroscopy, XRD, SEM, EDX, AFM (atomic force microscopy), profile, waviness, and roughness analyses. Antioxidant activity was screened based on ABTS<sup>Â·+</sup> radical scavenging and linoleic acid peroxidation performance. Cu-Npsâ€"Pyr-1b showed substantial antioxidant (97.2%) activity against ABTS<sup>Â·+</sup> assay and 91.2% activity against AAPH assays compared with Trolox. Cytotoxicity was evaluated using HepG2, HeLa, and MCF-7 cell lines, the Cu-Npsâ€"Pyr-1a is high in toxicities (GI<sub>50</sub> = 0.01â€‰<i>Î¼</i>m) against the HeLa cancel cell line compared with doxorubicin. The developed copper NPs with 2-pyrimidinamine (Cu-Npsâ€"Pyr) could provide promising advances as antioxidant activities; this nanocomposition could be considered an anticancer treatment in future investigations.</p> </div> <div class="funding-group" title="funding-group"> <div class="funding" title="funding">
Funding</div> <div class="award-group" title="award-group"> <div class="funding-source" title="funding-source">
King Saud University</div><span class="award-id" tagx="award-id" title="award-id">RSP-2020/27</span></div> </div> </div> </div> <div class="body" title="body"> <div class="1.introduction" title="sec"> <div class="title" tagx="title" title="title">
1. Introduction</div> <p>Pyrimidinamine has great importance as it is widely spread in living organisms and also a broad spectrum of biological activities such as antitumor properties [<a href="#B1">1</a>, <a href="#B2">2</a>], herbicidal [<a href="#B3">3</a>], fungicidal [<a href="#B4">4</a>], antidepressant [<a href="#B5">5</a>], and also, amino pyrimidine was an indicator of antitumor [<a href="#B6">6</a>], antibacterial [<a href="#B7">7</a>], and antiviral [<a href="#B8">8</a>] activities. The biological importance of natural and synthetic 2-pyrimidinamine core derivatives are shown in <a href="#fig1">Figure 1</a>, such as alkaloidal (divicine) properties found in fava beans, the aglycone of vicine [<a href="#B9">9</a>], the cytotoxic activity of alkaloid marine sponge (bromohymenialdisine) [<a href="#B10">10</a>], and antifeedant of alkaloid (dibromoisophakellin) [<a href="#B11">11</a>].</p> <p>Telmisartan is used in the management of hypertension, which acts as an angiotensin II receptor blocker (ARB). The structure of telmisartan is shown in <a href="#fig2">Figure 2</a> and their orally active direct-acting AII, the AT1receptor antagonist potential of pharmacotherapy of hypertension [<a href="#B12">12</a>].</p> <p>Scavenging ROS antioxidants of acetyl cysteine additionally L-carnitine are observed to cure the inflammatory diseases [<a href="#B13">13</a>, <a href="#B14">14</a>]. However, it does not performed well against ROS-related diseases due to poor bioavailability and various limitations of clinical screening [<a href="#B15">15</a>, <a href="#B16">16</a>]. Recently, studies reported that copper-based nanoparticles improved the ROS-related diseases and higher scavenging ability of this treatment [<a href="#B17">17</a>]. Copper (Cu) is one of the best elements in recommendation for human usage, which play an important role in tyrosinase and Cuâ€"ZnSOD enzyme [<a href="#B18">18</a>, <a href="#B19">19</a>]. Cu enzyme activity is basically a response to many bioactivities such as connective tissue biosynthesis, cellular respiration, neurotransmitter production, iron homeostasis, peptide biogenesis, pigment formation, and antioxidant defense [<a href="#B20">20</a>, <a href="#B21">21</a>]. Particularly, Cu-NPs has outstanding catalytic activity to scavenge H<sub>2</sub>O<sub>2</sub> and O<sub>2</sub> [<a href="#B22">22</a>] but cannot eliminate OHÂ· simultaneously [<a href="#B23">23</a>] and also can promote electron transfer reactions to inactivate H<sub>2</sub>O<sub>2</sub> or OHÂ· [<a href="#B24">24</a>]. The catalytic behavior of Cu compounds in organic reaction motivated us to focus our attention on the application of our research. As a result, we assume that the capacity of Cu-Nps acts as catalytic as well as antioxidant activities simultaneously. In addition, the stability of Cu-NPs can be largely enhanced, which is also developing the overall ROS scavenging ability [<a href="#B25">25</a>, <a href="#B26">26</a>]. Based on the above observation, we designed to synthesize, high active 2-pyrimidinamine connected with Cu nanoparticles and evaluated the antioxidant of ABTS<sup>Â·+</sup>, linoleic acid peroxidation, and cytotoxic activities.</p> </div> <div class="2.materialandmethods" title="sec"> <div class="title" tagx="title" title="title">
2. Material and Methods</div> <div class="2.1.generalmaterialsandcharacterizationtechniques" title="sec"> <div class="title" tagx="title" title="title">
2.1. General Materials and Characterization Techniques</div> <div class="2.1.1.chemistry" title="sec"> <div class="title" tagx="title" title="title">
2.1.1. Chemistry</div> <p>Telmisartan-mediated copper nanoparticle was analyzed from UV, FT-IR, SEM, X-ray with EDX, and AFM methods. FT-IR is recorded via Shimadzu 8201pc (4000-400â€‰cm<sup>âˆ’1</sup>). The <sup>1</sup>H and <sup>13</sup>C NMR were recorded via JEOL-300â€‰MHz. An elemental analyzer model (Varian EL III) was used for analysis of elemental presences. Thin layer chromatography was used for purity checking.</p> </div> </div> <div class="2.2.synthesisoftelmisartan-mediatedcoppernanoparticles" title="sec"> <div class="title" tagx="title" title="title">
2.2. Synthesis of Telmisartan-Mediated Copper Nanoparticles</div> <p>The mixture of CuCl<sub>2</sub>Â·2H<sub>2</sub>O (0.5â€‰mmol, 5â€‰mL) and telmisartan (1â€‰mmol, 10â€‰mL) was added in ethanol; then, the reaction mixture was allowed 1â€‰M NaOH with stirring and maintained pH = 7. The reaction mixture converted blue precipitate followed by adding of water (15â€‰mL). The precipitate was obtained, then filtered all precipitate and purified with suitable techniques.</p> </div> <div class="2.3.generalmethodforpreparationof2-pyrimidinaminederivatives(1a-1c)viabiginellireaction" title="sec"> <div class="title" tagx="title" title="title">
2.3. General Method for Preparation of 2-Pyrimidinamine Derivatives (1a-1c) via Biginelli Reaction</div> <p>The compound urea (0.01â€‰mol, 0.6â€‰g), Cu catalyst (0.01â€‰mol, 1.7â€‰g), ethyl acetoacetate (0.01â€‰mol, 1.3â€‰mL), benzaldehyde (0.01â€‰mol, 1â€‰mL), and substituted amine (0.05â€‰mol, 1.6â€‰mL) are mixed well together in a mortar and two drops of the con. HCl were added. The precipitate was dissolved in ethanol. The undissolved catalyst was filtered and dried in vacuum and used for the next cycle. The final product was obtained from the evaporation of ethanol from the filtrate and unexpected product also obtained. The final compound was confirmed by TLC. The pure product was obtained from the using suitable recrystallized method. The above procedure was followed for synthesis of the remaining compounds 1b and 1c.</p> </div> <div class="2.4.recyclabilityofcu-npcatalyst" title="sec"> <div class="title" tagx="title" title="title">
2.4. Recyclability of Cu-Np Catalyst</div> <p>Investigation of recovery the catalyst and usage via washing and dried with ethanol by under vacuum condition are shown.</p> <div class="2.4.1.ethyl2-hydrazono-6-methyl-4-phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxylate(1a)" title="sec"> <div class="title" tagx="title" title="title">
2.4.1. Ethyl 2-hydrazono-6-methyl-4-phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxylate (1a)</div> <p>The composition of 1a is as follows: black solid; mw: 274.32; mp 136Â°C; IR (cm<sup>âˆ’1</sup>): 3246.11 (NH), 3119.59 (Ph-CHstr), 3033.92 (Ar-H), 2597.00 (C=N), 1713.57 (OCOEt); <sup>1</sup>H NMR (300â€‰MHz, DMSO- d<sub>6</sub>): <i>Î´</i> 9.20 (2H, s, NH), 8.84 (2H, s, NH<sub>2</sub>), 7.33(2H, dd, <i>J</i> = 7.33Hz, <i>J</i> = 7.37â€‰Hz Ph), 7.28 (1H, d, <i>J</i> = 6.21â€‰Hz, phenyl), 7.23(2H, dd, <i>J</i> = 7.31â€‰Hz, <i>J</i> = 7.35â€‰Hz Ph), 4.20 (2H, m, -CH<sub>2</sub>) 4.16 (1H, d, <i>J</i> = 6.21â€‰Hz, -CH), 2.26 (3H, s, -CH<sub>3</sub>), 1.29 (3H, s, -CH<sub>3</sub>); <sup>13</sup>C NMR(300â€‰MHz, DMSO-d<sub>6</sub>): 167.2 (1C, <u>C</u>=O), 160.3(1C, -<u>C</u>-CH<sub>3</sub>), 154.0 (1C, C=N), 143.3, 128.5, 126.9, 126.7 (6C, Ar ring), 104.2 (1C, -<u>C-</u>CO-), 61.7(1C, -<u>C</u>-CH<sub>3</sub>), 45.1 (1C, -<u>C</u>-NH), 18.4 (1C, -CH<sub>3</sub>), 14.1 (1C, -CH<sub>3</sub>); elemental analysis: Calcd. for C<sub>14</sub>H<sub>18</sub>N<sub>4</sub>O<sub>2</sub>: elemental analysis: C, 61.30; H, 6.61; N, 20.42%; found: C, 61.27; H, 6.62; N, 20.45%.</p> </div> <div class="2.4.2.ethyl6-methyl-4-phenyl-2-(2-phenylhydrazono)-1,2,3,4-tetrahydropyrimidine-5-carboxylate(1b)" title="sec"> <div class="title" tagx="title" title="title">
2.4.2. Ethyl 6-methyl-4-phenyl-2-(2-phenylhydrazono)-1,2,3,4-tetrahydropyrimidine-5-carboxylate (1b)</div> <p>The composition of 1b is as follows: grey solid; mw: 350.41; mp:184Â°C; IR (cm<sup>âˆ’1</sup>): 3239.20 (NH), 3128.82 (Ph-CHstr), 2596.43 (C=N), 1715.02 (OCOEt); <sup>1</sup>H NMR (300â€‰MHz, DMSO- d<sub>6</sub>): <i>Î´</i> 11.12 (1H, s, NH), 9.34 (2H, s, NH), 7.35 (2H, dd, <i>J</i> = 7.33â€‰Hz, <i>J</i> = 7.37â€‰Hz Ph), 7.33 (2H, dd, <i>J</i> = 7.33â€‰Hz, <i>J</i> = 7.37â€‰Hz Ph), 7.29 (1H, d, <i>J</i> = 6.21â€‰Hz, Phenyl), 7.23 (2H, dd, <i>J</i> = 7.31â€‰Hz, <i>J</i> = 7.35â€‰Hz Ph), 7.20 (2H, dd, <i>J</i> = 7.31â€‰Hz, <i>J</i> = 7.35â€‰Hz Ph), 6.81 (1H, d, <i>J</i> = 6.21â€‰Hz, phenyl), 4.20 (2H, m, - CH<sub>2</sub>) 4.12 (1H, d, <i>J</i> = 6.21â€‰Hz, -CH), 2.26 (3H, s, -CH<sub>3</sub>), 1.29 (3H, s, -CH<sub>3</sub>); <sup>13</sup>C NMR (300â€‰MHz, DMSO-d<sub>6</sub>): 167.2 (1C, <u>C</u>=O), 160.3(1C, -<u>C</u>-CH<sub>3</sub>), 154.0 (1C, C=N), 143.3, 128.5, 126.9, 126.7(6C, Ar ring), 143.0, 113.9, 129.5, 122.4 (6C, Ar ring), 104.2 (1C, -<u>C-</u>CO-), 61.7 (1C, -<u>C</u>-CH<sub>3</sub>), 45.1(1C, -<u>C</u>-NH), 18.4 (1C, -CH<sub>3</sub>) 14.1 (1C, -CH<sub>3</sub>); elemental analysis: Calcd. for C<sub>20</sub>H<sub>22</sub>N<sub>4</sub>O<sub>2</sub>: C, 68.55; H, 6.33; N, 15.99 %; found: C, 68.52; H, 6.37; N, 15.98%.</p> </div> <div class="2.4.3.ethyl2-(carbamothioylimino)-6-methyl-4-phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxylate(1c)" title="sec"> <div class="title" tagx="title" title="title">
2.4.3. Ethyl 2-(carbamothioylimino)-6-methyl-4-phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxylate (1c)</div> <p>The composition of 1c is as follows: white solid; mw: 318.39; mp:236Â°C; IR (cm<sup>âˆ’1</sup>): 3239.02 (NH), 3128.82 (Ph-CHstr), 2596.43 (C=N), 1715.02 (OCOEt), 1094.82 (C=S); <sup>1</sup>H NMR (300â€‰MHz, DMSO- d<sub>6</sub>): <i>Î´</i> 9.26 (2H, s, NH), 8.84 (2H, s, NH<sub>2</sub>), 7.33 (2H, dd, <i>J</i> = 7.33â€‰Hz, <i>J</i> = 7.37â€‰Hz Ph), 7.25 (1H, d, <i>J</i> = 6.21â€‰Hz, phenyl), 7.23 (2H, dd, <i>J</i> = 7.31â€‰Hz, <i>J</i> = 7.35â€‰Hz Ph), 4.20 (2H, m, - CH<sub>2</sub>), 4.10 (1H, d, <i>J</i> = 6.21â€‰Hz, -CH), 2.26 (3H, s, -CH<sub>3</sub>), 1.29 (3H, s, -CH<sub>3</sub>); <sup>13</sup>C NMR(300â€‰MHz, DMSO-d<sub>6</sub>): 190.0 (1C, C=S), 167.2 (1C, <u>C</u>=O), 160.3(1C, -<u>C</u>-CH<sub>3</sub>), 163.0 (1C, C=N), 143.3, 128.5, 126.9, 126.7 (6C, Ar ring), 104.2 (1C, -<u>C-</u>CO-), 61.7 (1C, -<u>C</u>-CH<sub>3</sub>), 45.1 (1C, -<u>C</u>-NH), 18.4 (1C, -CH<sub>3</sub>), 14.1 (1C, -CH<sub>3</sub>); elemental analysis: Calcd. for C<sub>15</sub>H<sub>18</sub>N<sub>4</sub>O<sub>2</sub>S: C, 56.58; H, 5.70; N, 17.60%; found: C, 56.60; H, 5.71; N, 17.57%.</p> </div> </div> <div class="2.5.antioxidantâ€" title="sec"> <div class="title" tagx="title" title="title">
2.5. Antioxidantâ€"(ABTS<sup>Â·+</sup>) Scavenging Activity</div> <p>ABTS<sup>+</sup> (2,2â€²-azino-bis(3-ethylbenzothiazoline-6-sulfonicacid)), the antioxidant radical scavenging activity, was checked with all compounds via spectrophotometric analysis according to the method descripted in Surendra Kumar et al. [<a href="#B27">27</a>]. The ABTS<sup>Â·+</sup> radical scavenging is established and calculated the ability of antioxidants via characteristic absorption at 734â€‰nm for long-lived ABTS radical cation, which indicated that blue/green chromophore. The results are shown in <a href="#tab1">Table 1</a>. The tested reaction mixture was prepared by 7â€‰mM aqueous ABTS with 2.45â€‰mM potassium per sulfate at 12â€‰h maintained in the dark room with formal temperature. Prior to the experiment, a range of absorbance 0.700 Â± 0.025 at 734â€‰nm was obtained by the ABTS<sup>Â·<b>+</b></sup> solution was diluted with phosphate buffer (0.1â€‰M, pHâ€‰7.4) and added with 1â€‰mL of the diluted 1.5â€‰mL ethanolic solutions of 1a-c, Cu-Nps, and Cu-Nps-Pyr (1a-1c) with different concentrations (100â€‰<i>Î¼</i>g/mL). After 30â€‰min, the percentage of inhibition was calculated at 734â€‰nm. Ethanol is used as a blank sample, following the formula used for analysis of the percentage of inhibition. </p><div class="disp-formula" title="disp-formula"><span class="label" tagx="label" title="label">(1)</span><div class="math_UNKNOWN"> <div class="mtable_UNKNOWN"> <div class="mtr_UNKNOWN"> <div class="mtd_UNKNOWN"> <div class="mtext_UNKNOWN">
ABTS</div> <div class="mo_UNKNOWN">
+</div> <div class="mtext_UNKNOWN">
scavenging</div> <div class="mtext_UNKNOWN" /> <div class="mtext_UNKNOWN">
effect</div> <div class="mtext_UNKNOWN" /> <div class="mfenced_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
%</div> </div> </div> <div class="mo_UNKNOWN">
=</div> <div class="mfenced_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mfrac_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mfenced_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="msub_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
A</div> </div> <div class="mrow_UNKNOWN"> <div class="mtext_UNKNOWN">
c</div> </div> </div> <div class="mo_UNKNOWN">
â€"</div> <div class="msub_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
A</div> </div> <div class="mrow_UNKNOWN"> <div class="mtext_UNKNOWN">
s</div> </div> </div> </div> </div> </div> <div class="mrow_UNKNOWN"> <div class="msub_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
A</div> </div> <div class="mrow_UNKNOWN"> <div class="mtext_UNKNOWN">
c</div> </div> </div> </div> </div> </div> </div> <div class="mo_UNKNOWN">
Ã—</div> <div class="mn_UNKNOWN">
100</div> <div class="mi_UNKNOWN">
%</div> <div class="mo_UNKNOWN">
,</div> </div> </div> </div></div></div>where <i>A</i><sub>c</sub>â€‰=â€‰initial ABTS<sup>Â·<b>+</b></sup> absorbance and <i>A</i><sub>s</sub>â€‰=1aâ€"c, Cu-Nps, and Cu-Nps-Pyr (1a-1c) absorbance.<p /> </div> <div class="2.6.inhibitionofaaphassayfreeradicalanalysis" title="sec"> <div class="title" tagx="title" title="title">
2.6. Inhibition of AAPH Assay Free Radical Analysis</div> <p>This linoleic acid peroxidation assay was achieved and followed the methods of Surendra Kumar et al. [<a href="#B27">27</a>]. All values were carried out in triplicate, with the consistent data, provided in <a href="#tab1">Table 1</a>. The oxidation of linoleic acid production was analyzed by conjugated diene hydroperoxide in an aqueous distribution was observed at 234â€‰nm, [<a href="#B28">28</a>] with AAPH (2,2â€²-azobis(2-amidinopropane) dihydrochloride) used as a free radical initiator. For UV cuvette solution preparation, 1â€‰mL aliquot of a 16â€‰mM linoleic acid was added to 1â€‰mL of 0.05â€‰M phosphate buffer(pHâ€‰7.4), thermostatic at 37Â°C and addition of 1â€‰mL of the 40â€‰mM AAPH solution. Oxidation reaction was monitored in occurrence of 1â€‰mL of the tested compounds 1a-c, Cu-Nps, and Cu-Nps-Pyr (1a-1c). In the absence of antioxidants, the lipid oxidation was monitored in DMSO mixed compounds. The rate of oxidation was monitored at 37Â°C and absorption recorded at 234â€‰nm due to the formation of a conjugated diene hydroperoxide.</p> <p>The percentage of linoleic acid oxidation inhibition was calculated as follows: </p><div class="disp-formula" title="disp-formula"><span class="label" tagx="label" title="label">(2)</span><div class="math_UNKNOWN"> <div class="mtable_UNKNOWN"> <div class="mtr_UNKNOWN"> <div class="mtd_UNKNOWN"> <div class="mi_UNKNOWN">
%</div> <div class="mtext_UNKNOWN">
Inhibition</div> <div class="mo_UNKNOWN">
=</div> <div class="mfenced_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mfrac_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mfenced_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mn_UNKNOWN">
1</div> <div class="mo_UNKNOWN">
â€"</div> <div class="mtext_UNKNOWN">
rate</div> <div class="mtext_UNKNOWN" /> <div class="mtext_UNKNOWN">
of</div> <div class="mtext_UNKNOWN" /> <div class="mtext_UNKNOWN">
absorbance</div> <div class="mtext_UNKNOWN" /> <div class="mtext_UNKNOWN">
with</div> <div class="mtext_UNKNOWN" /> <div class="mtext_UNKNOWN">
test</div> <div class="mtext_UNKNOWN" /> <div class="mtext_UNKNOWN">
compound</div> </div> </div> </div> <div class="mrow_UNKNOWN"> <div class="mtext_UNKNOWN">
rate</div> <div class="mtext_UNKNOWN" /> <div class="mtext_UNKNOWN">
of</div> <div class="mtext_UNKNOWN" /> <div class="mtext_UNKNOWN">
absorbance</div> <div class="mtext_UNKNOWN" /> <div class="mtext_UNKNOWN">
with</div> <div class="mtext_UNKNOWN" /> <div class="mtext_UNKNOWN">
solvent</div> <div class="mtext_UNKNOWN" /> <div class="mtext_UNKNOWN">
control</div> </div> </div> </div> </div> <div class="mo_UNKNOWN">
Ã—</div> <div class="mn_UNKNOWN">
100</div> <div class="mi_UNKNOWN">
%</div> <div class="mo_UNKNOWN">
.</div> </div> </div> </div></div></div> <p /> </div> <div class="2.7.cytotoxicactivity" title="sec"> <div class="title" tagx="title" title="title">
2.7. Cytotoxic Activity</div> <p>The synthesized compounds 1a-c, Cu-Nps, and Cu-Nps -Pyr (1a-1c) were screened for cytotoxic activity, and we followed the methods of Surendra Kumar et al. [<a href="#B27">27</a>, <a href="#B29">29</a>]. The 100â€‰<i>Î¼</i>M (MTT anticancer assay) concentration treated with test compounds for 48â€‰h was used by three cell lines (HepG2, HeLa, and MCF-7), and standard of doxorubicin was selected in this screening.</p> <p>The results were analyzed between the growth percentage of treated cells and untreated control cells. Sample preparation, 0.1â€‰mL of the test solution (6.25â€"100â€‰<i>Î¼</i>g in 1% DMSO), and 0.1â€‰mL aliquot of the cell suspension (5 Ã— 10<sup>6</sup> cells/100â€‰<i>Î¼</i>L) were added and kept in an incubator (5% CO<sub>2</sub>) at 37Â°C for 72â€‰h. The blank sample checked only the cell suspension, and the control wells contained 1% DMSO and the cell suspension. After 72â€‰h, 20â€‰<i>Î¼</i>L of MTT was added, and the plates were kept in the CO<sub>2</sub> incubator for 2â€‰h, followed by the addition of propanol (100â€‰<i>Î¼</i>L). The absorption data (562â€‰nm) were obtained by 27-well plates on an ELISA reader; the test sample was prepared by aluminum foil covered with subsequently agitated in a rotary shaker for 10â€"20â€‰min.</p> </div> <div class="2.8.statisticalanalysis" title="sec"> <div class="title" tagx="title" title="title">
2.8. Statistical Analysis</div> <p>Antioxidant activities results were calculated through 3 independent evaluations, and Microsoft Excel was used to analysis the standard deviations (SD) of each compound.</p> </div> </div> <div class="3.resultanddiscussion" title="sec"> <div class="title" tagx="title" title="title">
3. Result and Discussion</div> <p>The one-pot multicomponent 2-pyrimidinamine was synthesized with in high yields. The most important factor was only excellent yield, which was a performance of suitable catalysis with aromatic aldehyde performance including hydroxyl groups reacted efficiently.</p> <p>A series of compounds were prepared via optimizing the reaction conditions, for instance of reaction involved among benzaldehyde, ethyl acetoacetate, substituted amine, and urea using Cu-Nps as a catalyst in a suitable solvent (<a href="#sch1">Scheme 1</a>). The amount of Cu-Nps was changed subsequently from 0â€‰mol% to 5â€‰mol% under solvent-free conditions, as a result of the optimized mole percentage and the 88% yield performance obtained at 1â€‰mol% concentration. Therefore, the results directed that 1â€‰mol% of Cu-Nps is enough for the synthesis of the 2-pyrimidinamine compound. The synthesized Cu-Nps were characterized by UV, FT-IR spectroscopy, SEM, XRD, EDX, AFM (atomic force microscopy), profile, waviness, and roughness analyses.</p> <div class="3.1.ft-irstudies" title="sec"> <div class="title" tagx="title" title="title">
3.1. FT-IR Studies</div> <p>The main characteristic experimental vibrations of Cu-Nps are obtained from FT-IR shown in <a href="#fig3">Figure 3</a>. The literature data of IR values were referred to the analysis of the vibrational frequency presence in the compounds. For spectral values of Oâˆ’H and Câˆ’H stretching, the vibration frequency range was obtained at 4000âˆ’2000â€‰cm<sup>âˆ’1</sup>. The Oâˆ’H stretching in water molecules was assigned at 3432â€‰cm<sup>âˆ’1</sup> for Cu-Nps. The mode of the antisymmetric and the symmetric carboxylate groups was observed at 1593â€‰cm<sup>âˆ’1</sup> (s, FT-IR) and 1391â€‰cm<sup>âˆ’1</sup>(vs. FT-IR), respectively. Biphenyl group was found in the IR range between 1600 and 1400â€‰cm<sup>âˆ’1</sup>, respectively. The COOH bends and C-N (Bz) stretching modes was observed at 1235â€‰cm<sup>âˆ’1,</sup> respectively.</p> </div> <div class="3.2.uv-visiblestudies" title="sec"> <div class="title" tagx="title" title="title">
3.2. UV-Visible Studies</div> <p>Spectrophotometric analysis was carried out for the Cu-Np catalyst. 6.25â€‰mM of telmisartan was added with different copper concentrations with the addition of 1â€‰M NaOH (pHâ€‰7) for every tested compound. The UV-visible spectra are shown in <a href="#fig4">Figure 4</a>. The Cu-Nps showed absorption bands located at 530â€‰nm (sh).</p> </div> <div class="3.3.semandedxanalyses" title="sec"> <div class="title" tagx="title" title="title">
3.3. SEM and EDX Analyses</div> <p><a href="#fig5">Figure 5</a> illustrates SEM images of Cu-Nps obtained in water (a) and in formamide mixture (b). The telmisartan-mediated Cu-Nps in the formamide mixture shows cubic in nature with size in the range of 1â€‰<i>Î¼</i>m (c). <a href="#fig6"> Figure 6</a> illustrates the EDX of Cu-Nps that exhibited the elements (Cu, C, and O) in the nanoparticle, thereby confirming the formation of the nanoparticle. <a href="#tab2"> Table 2</a> shows the EDX analysis of percentage of elements present in the Cu-Np catalyst.</p> </div> <div class="3.4.powderx-raydiffractionstudies" title="sec"> <div class="title" tagx="title" title="title">
3.4. Powder X-Ray Diffraction Studies</div> <p>The structural analysis and phase crystallinity of the synthesized Cu-Nps were examined via the powder X-ray diffraction method. <a href="#fig7"> Figure 7</a> signifies a Cu nanoparticle diffraction pattern at a 2<i>Î¸</i> value of 43.20Â°, 50.42Â°, and 74.15Â° respect to (111), (200), and (220) planes individually; it conformed the formation of copper cubic lattice. JCPDS No. 040836 indicates the good agreement and comparison with the standard pattern for pure face centered cubic phase of copper nanoparticles. There are no impurity peaks observed. The strong peaks indicate the highly crystalline nature of the formed nanoparticles. From the observed main diffracted peak, the average crystalline size can be calculated using the Scherer equation. </p><div class="disp-formula" title="disp-formula"><span class="label" tagx="label" title="label">(3)</span><div class="math_UNKNOWN"> <div class="mtable_UNKNOWN"> <div class="mtr_UNKNOWN"> <div class="mtd_UNKNOWN"> <div class="msub_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
D</div> </div> <div class="mrow_UNKNOWN"> <div class="mfenced_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mtext_UNKNOWN">
hkl</div> </div> </div> </div> </div> <div class="mo_UNKNOWN">
=</div> <div class="mfrac_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
k</div> <div class="mi_UNKNOWN">
Î»</div> </div> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
Î²</div> <div class="mi_UNKNOWN">
cos</div> <div class="mi_UNKNOWN">
Î¸</div> </div> </div> <div class="mo_UNKNOWN">
,</div> </div> </div> </div></div></div>where <i>D</i><sub>(hkl)</sub> is the average crystalline size, <i>k</i> is shape constant (0.89), <i>Î»</i> is the incident X-ray (CuK<i>Î±</i> source, <i>Î»</i> = 0.15405â€‰nm), <i>Î²</i> is the full-width half-maximum, and <i>Î¸</i> is the incident angle of X-ray. The average crystallite size of the synthesized copper nanoparticles was 25.41â€‰nm.<p /> </div> <div class="3.5.atomicforcemicroscopestudies" title="sec"> <div class="title" tagx="title" title="title">
3.5. Atomic Force Microscope Studies</div> <p><a href="#fig8">Figure 8</a> shows AFM images of Cu-Nsp. AFM image indicates the filtering procedure at cut-off frequency values at 4â€‰<i>Î¼</i>m and Cu-Nsp profile particle size; performance is presented in <a href="#fig8">Figure 8(b)</a>, which obtained a value of 253â€‰nm for the unfiltered profile. Figures <a href="#fig8">8(c)</a> and <a href="#fig8">8(d)</a> indicated the Cu-Np waviness and roughness, which were 234â€‰nm for waviness and 14â€‰nm for the roughness profile. Therefore, such values indicate that the unfiltered roughness parameter of shape and binding dominate Cu nanoparticles.</p> </div> <div class="3.6.tga/dtastudies" title="sec"> <div class="title" tagx="title" title="title">
3.6. TGA/DTA Studies</div> <p>The compound was displayed by total weight loss in three stages. In the first stage, the weight loss occurred in the temperature range about 40-220Â°C representing the vapor liberation in the sample. The weight loss befell in the second stage at the temperature range between 220 and 450Â°C consistent to the liberation of vapor from the inner apertures of Cu. The weight loss in the third stage happens between the temperature ranges of 450-800Â°C display indulgences of carbonaceous material of the sample. Organic material presence in the sample, was observed at exothermic peak of 290Â°C. The TGA/DTA profile for the Cu-Np precursor was shown in <a href="#fig9">Figure 9</a>.</p> </div> <div class="3.7.particlesizeanalyzerstudies" title="sec"> <div class="title" tagx="title" title="title">
3.7. Particle Size Analyzer Studies</div> <p>For a particle size analyzer, the first peak indicates 206.4â€‰nm diameter and standard deviation 38.4â€‰nm, which indicates 206.4â€‰nm average nanoparticle presence in the target nanocatalysis. <a href="#fig10"> Figure 10</a> shows different intensity vs. diameter of the first peak of Cu-Nps.</p> </div> <div class="3.8.catalystrecoverystudies" title="sec"> <div class="title" tagx="title" title="title">
3.8. Catalyst Recovery Studies</div> <p><a href="#fig11">Figure 11</a> indicated the recovery of the catalyst with salvaged for at least 10 run times and slight loss in catalytic activity. The lessening of activity could be detected with the regenerated catalyst on salvaging due to surface area of the catalyst during the reaction or partial loss of basic sites/regeneration. The values are shown in <a href="#tab3">Table 3</a>.</p> <p>The application of the catalyst was inspected via optimizing the reaction conditions. A number of aromatic aldehydes were selected to go through the condensation reaction with Cu-Nps (1â€‰mol %) catalytic at room temperature in solvent-free settings, the yield reported in <a href="#tab3">Table 3</a>. The Cu-catalyzed performance and reaction mechanism are shown in <a href="#sch2">Scheme 2</a>.</p> <p>The intermediate of acyl imine formed between urea reacts with primary amine; for the next step, acyl imine reacted with aldehyde to give the guanidine core, which is actuated by copper catalysis. Step 3 was addition reaction between <i>Î²</i>-dicarbonyl with 1-benzylidene-2-R-guanidine, then cyclized to afford the 2-aminopyrimidine derivatives. In conclusion, the simple and efficient synthesis of 2-aminopyrimidine uses Cu-Nps under solvent-free conditions. We developed the methodology and environmentally safe synthesis of the 2-aminopyrimidine derivative with good yields.</p> <p>Compounds 1a-1c were synthesized by condensation method. The compounds 1a-1c physicochemical data are represented in <a href="#tab4">Table 4</a> and its catalyst performance is shown in <a href="#tab5">Table 5</a>. The compounds were confirmed via FT-IR, <sup>1</sup>H and <sup>3</sup>C NMR spectra, and elemental analyses. The IR absorption bands of compound 1a show the frequency range between 2584 and 2596 and 3239 and 3246â€‰cm<sup>âˆ’1</sup> corresponding to the C=N and NH groups, respectively.</p> <p>For compound 1a, the <sup>1</sup>H NMR spectral value obtained a sharp singlet at <i>Î´</i> 9.20 for NH proton and a singlet at <i>Î´</i> 4.16 for -CH- proton, <sup>13</sup>C NMR spectral values at <i>Î´</i> 167.2 and <i>Î´</i> 154.0â€‰ppm corresponding to C=O and C=N carbons, respectively. The IR absorption bands show that compound 1b frequency ranges between 3239 and 3246 and 2584 and 2596â€‰cm<sup>âˆ’1</sup> corresponding to the NH and C=N groups, respectively. For compound 1b, <sup>1</sup>H NMR spectral value obtained a sharp singlet at <i>Î´</i> 9.34 for NH proton and a singlet at <i>Î´</i> 4.12 for -CH- proton, <sup>13</sup>C NMR spectra of compound peaks at <i>Î´</i> 167.0 and <i>Î´</i>154.8â€‰ppm corresponding to C=O and C=N carbons, respectively.</p> <p>For compound 1c, IR spectra show absorption bands in 2584â€"2596 and 3239-3246â€‰cm<sup>âˆ’1</sup> corresponding to the C=N and NH groups, respectively. For compound 1c, <sup>1</sup>H NMR spectral value obtained a sharp singlet at <i>Î´</i> 9.26 for NH proton and a singlet at <i>Î´</i> 4.10 for -CH- proton; <sup>13</sup>C NMR spectral value obtained the peaks at <i>Î´</i> 163.0, 167.2, and 190.0â€‰ppm corresponding to C=N, C=O, and C=S carbons, respectively.</p> <p><a href="#sch3">Scheme 3</a> indicates that the mechanism of expected product and unexpected copper nanoparticles connected 2-pyrimidine compounds; this mechanism clearly indicated the necessity for evaluation of the biological activity in 1aâ€"c, Cu-Nps, and unexpected copper nanoparticles connected 2-pyrimidine Cu-Nps-Pyr (1a-1c) compounds.</p> </div> <div class="3.9.abtsÂ·+radicalscavengingactivity" title="sec"> <div class="title" tagx="title" title="title">
3.9. ABTS<sup>Â·+</sup> Radical Scavenging Activity</div> <p>The antioxidant activity was carried out based on a decolorization technique using the ABTS radical assay, with the generation of the stable blue/green ABTS<sup>Â·+</sup> radical formation. Among the synthesized compounds, Cu-Nps-Pyr-1b showed capable ABTS<sup>Â·+</sup> scavenging activities of 97.2%, compared with Trolox standard (<a href="#tab1">Table 1</a>).</p> <p>This study, containing both 2-pyrimidinamine and Cu-Nps, shows the capability to scavenge ABTS<sup>Â·+</sup> assays compared with standard; the mechanism is represented in <a href="#sch4">Scheme 4</a>.</p> </div> <div class="3.10.cu-npsâ€" title="sec"> <div class="title" tagx="title" title="title">
3.10. Cu-Npsâ€"Pyr-1c-Linoleic Acid Peroxidation-Inhibition</div> <p>The Cu-Nsp with 2-pyrimidinamine combination was highly responsive to oxidative changes and inhibition in linoleic acid peroxidation screening. The hydrophilic AAPH initiator was used to measure the conjugated diene hydroperoxide formation at 234â€‰nm by spectrophotometric analysis. Indeed, AAPH produced the free radicals at 37Â°C, which was an act of spontaneous decomposition. Here, Râ€"N=Nâ€"R indicates the radical initiator, and LOO<sup>Â·</sup> denotes a linoleic peroxy radical, and LH stands for linoleic acid. The radicals R<sup>Â·</sup> was produced via immediately reacting with oxygen and causing the oxidation of lipids. The mechanism of reaction is represented in <a href="#sch5">Scheme 5</a>.</p> <p>The Cu-Nsp with 2-pyrimidinamine derivatives was performed by hydrogen donor antioxidants (AOH), steadying and postponing the free radicals of oxidation lipids. In <i>in vitro</i> studies of free radical fabrication, an azo compound was causing free radicals by impulsive thermal decomposition. Alkylperoxy free radicals were produced via the water-soluble AAPH used as a hygienic and governable source thermally. AAPH assay was achieved to enhance the antioxidant activity of Cu-Nsp with 2-pyrimidinamine; the compound 1c and Cu-Nps-Pyr-1c are awarding activities of 75.6 and 91.2%, respectively, at a concentration of 100â€‰<i>Î¼</i>g/mL.</p> </div> <div class="3.11.cytotoxicactivity" title="sec"> <div class="title" tagx="title" title="title">
3.11. Cytotoxic Activity</div> <p>The results of each compound were reported in <a href="#tab6">Table 6</a>. The results show the contacts of LC<sub>50</sub>, TGI, and GI<sub>50</sub> values. The compound 1a (GI<sub>50</sub> = 0.69<i>Î¼</i>M) was high, while Cu-Nps-Pyr-1a (GI<sub>50</sub> = 0.01â€‰<i>Î¼</i>m) showed a significant activity against the HeLa cancer cell line. The compound 1b (GI<sub>50</sub> = 02.1â€‰<i>Î¼</i>M) and Cu-Nps-Pyr-1b (GI<sub>50</sub> = 0.01â€‰<i>Î¼</i>M) showed rightful activity against the HepG2 cell line compared with standard doxorubicin. All compounds displayed a moderate activity against all the cell line, whereas when compound with Cu nanoparticles, it is becoming highly responsive in cytotoxic scanning.</p> </div> </div> <div class="4.conclusion" title="sec"> <div class="title" tagx="title" title="title">
4. Conclusion</div> <p>In conclusion, for copper nanoparticles mediated by the telmisartan drug, the Cu-Nsp was characterized by UV and FT-IR spectroscopy, scanning electron microscopy, X-Ray, EDX, AFM (atomic force microscopy), profile, waviness, roughness analysis, TGA studies and particle size analyzer. Synthesized Cu-Nps were used as catalysis for preparation of pyrimidinamine via the Biginelli multicomponent cyclocondensation reaction. The Cu-Nsp was a significantly active catalyst and gave excellent yields, and also recycling of the catalyst is very easy in this process. Bioactivity of 2-pyrimidinamine was a significant activity against performance of ABTS<sup>Â·+</sup> and linoleic acid peroxidation, while Cu-Nsp was moderately active in antioxidant screening; therefore, designed 2-pyrimidinamine with Cu-Nsp gave a noble result when compared with commercial drugs. Particularly, Cu-Nps-Pyr-1b was a potential activity (&amp;gt;90%) against ABTS<sup>Â·+</sup> and AAPH assays, as compared with the Trolox standard. In cytotoxicity activity, the compound Cu-Nps-Pyr-1a was perceived for (GI<sub>50</sub> = 0.01â€‰<i>Î¼</i>m) against the HeLa cell line compared with doxorubicin. It is noteworthy that Cu-Nps with 2-pyrimidinamine and their derivatives are medicinally important as anticancer treatment, and future investigation of <i>in vivo</i> screening and the mechanism of action is currently undergoing study.</p> </div> </div> <div class="back" title="back"> <div class="ack" title="ack"> <div class="title" tagx="title" title="title">
Acknowledgments</div> <p>This work was funded by Researchers Supporting Project number (RSP-2020/27), King Saud University, Riyadh, Saudi Arabia.</p> </div> <div class="data-availability" title="data-availability"> <div class="title" tagx="title" title="title">
Data Availability</div> <p>The data used to support the findings of this study are available from the corresponding author upon request.</p> </div> <div class="COI-statement" title="COI-statement"> <div class="title" tagx="title" title="title">
Conflicts of Interest</div> <p>The authors declare that they have no conflict of interest.</p> </div> <div class="authors'contributions" title="sec"> <div class="title" tagx="title" title="title">
Authors' Contributions</div> <p>A.I conceived, designed, and coordinated the study. R.S, S.A, and C.S collected the data. N.A.A. was responsible for the statistical analysis. All authors contributed to data analysis and interpretation. All authors read, reviewed, and approved this current version for publication.</p> </div> <div class="references">
References</div> <div tag="ref-list"> <ul> <li tag="ref"><a name="B1" /><span class="label" tagx="label" title="label">1</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gong</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hong</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kohm</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis, SAR, and antitumor properties of diamino- C , N -diarylpyrimidine positional isomers: inhibitors of lysophosphatidic acid acyltransferase-<i>Î²</i></span><span class="source" tagx="source" title="source"><i>Bioorganic &amp;amp; Medicinal Chemistry Letters</i></span><span class="year" tagx="year" title="year">2004</span><span class="volume" tagx="volume" title="volume">14</span><span class="issue" tagx="issue" title="issue">9</span><span class="fpage" tagx="fpage" title="fpage">2303</span><span class="lpage" tagx="lpage" title="lpage">2308</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.bmcl.2004.01.104">10.1016/j.bmcl.2004.01.104</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15081029">15081029</a></span></span></li> <li tag="ref"><a name="B2" /><span class="label" tagx="label" title="label">2</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jeong</span><span class="given-names" tagx="given-names" title="given-names">L. S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">L. X.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Choi</span><span class="given-names" tagx="given-names" title="given-names">W. J.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and antitumor activity of fluorocyclopentenyl- pyrimidines</span><span class="source" tagx="source" title="source"><i>Nucleosides Nucleotides Nucleic Acids</i></span><span class="year" tagx="year" title="year">2007</span><span class="volume" tagx="volume" title="volume">26</span><span class="issue" tagx="issue" title="issue">6-7</span><span class="fpage" tagx="fpage" title="fpage">713</span><span class="lpage" tagx="lpage" title="lpage">716</span><span class="pub-id"><a href="https://dx.doi.org/10.1080/15257770701490852">10.1080/15257770701490852</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/18066886">18066886</a></span></span></li> <li tag="ref"><a name="B3" /><span class="label" tagx="label" title="label">3</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pan</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Z.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">Y. W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Y. H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Z. M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Design, synthesis and herbicidal activity of novel sulfonylureas containing monosubstituted pyrimidine moiety</span><span class="source" tagx="source" title="source"><i>Chemical Journal of Chinese Universities</i></span><span class="year" tagx="year" title="year">2013</span><span class="volume" tagx="volume" title="volume">34</span><span class="fpage" tagx="fpage" title="fpage">1416</span><span class="lpage" tagx="lpage" title="lpage">1422</span><span class="pub-id"><a href="https://dx.doi.org/10.7503/cjcu20120972">10.7503/cjcu20120972</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B4" /><span class="label" tagx="label" title="label">4</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Milling</span><span class="given-names" tagx="given-names" title="given-names">R. J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Richardson</span><span class="given-names" tagx="given-names" title="given-names">C. J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Mode of action of the anilino-pyrimidine fungicide pyrimethanil. 2. Effects on enzyme secretion <i>in Botrytis cinerea</i></span><span class="source" tagx="source" title="source"><i>Pesticide Science</i></span><span class="year" tagx="year" title="year">1995</span><span class="volume" tagx="volume" title="volume">45</span><span class="issue" tagx="issue" title="issue">1</span><span class="fpage" tagx="fpage" title="fpage">43</span><span class="lpage" tagx="lpage" title="lpage">48</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/ps.2780450107">10.1002/ps.2780450107</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B5" /><span class="label" tagx="label" title="label">5</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bernier</span><span class="given-names" tagx="given-names" title="given-names">J. L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Henichart</span><span class="given-names" tagx="given-names" title="given-names">J. P.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Warin</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Baert</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and structure-activity relationship of a pyrimido[4,5-d]pyrimidine derivative with antidepressant activity</span><span class="source" tagx="source" title="source"><i>Journal of Pharmaceutical Sciences</i></span><span class="year" tagx="year" title="year">1980</span><span class="volume" tagx="volume" title="volume">69</span><span class="issue" tagx="issue" title="issue">11</span><span class="fpage" tagx="fpage" title="fpage">1343</span><span class="lpage" tagx="lpage" title="lpage">1345</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/jps.2600691128">10.1002/jps.2600691128</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/6256515">6256515</a></span></span></li> <li tag="ref"><a name="B6" /><span class="label" tagx="label" title="label">6</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kim</span><span class="given-names" tagx="given-names" title="given-names">K. H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jeong</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Discovery of a novel class of 2-aminopyrimidines as CDK1 and CDK2 inhibitors</span><span class="source" tagx="source" title="source"><i>Bioorganic and Medicinal Chemistry Letters</i></span><span class="year" tagx="year" title="year">2011</span><span class="volume" tagx="volume" title="volume">21</span><span class="issue" tagx="issue" title="issue">14</span><span class="fpage" tagx="fpage" title="fpage">4203</span><span class="lpage" tagx="lpage" title="lpage">4205</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.bmcl.2011.05.081">10.1016/j.bmcl.2011.05.081</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21684737">21684737</a></span></span></li> <li tag="ref"><a name="B7" /><span class="label" tagx="label" title="label">7</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hawser</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lociuro</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Islam</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Dihydrofolate reductase inhibitors as antibacterial agents</span><span class="source" tagx="source" title="source"><i>Biochemical Pharmacology</i></span><span class="year" tagx="year" title="year">2006</span><span class="volume" tagx="volume" title="volume">71</span><span class="issue" tagx="issue" title="issue">7</span><span class="fpage" tagx="fpage" title="fpage">941</span><span class="lpage" tagx="lpage" title="lpage">948</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.bcp.2005.10.052">10.1016/j.bcp.2005.10.052</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/16359642">16359642</a></span></span></li> <li tag="ref"><a name="B8" /><span class="label" tagx="label" title="label">8</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">HockovÃ¡</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">HolÃ½</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">MasojÃ­dkovÃ¡</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">5-Substituted-2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidinesAcyclic nucleoside phosphonate analogues with antiviral activity</span><span class="source" tagx="source" title="source"><i>Journal of Medicinal Chemistry</i></span><span class="year" tagx="year" title="year">2003</span><span class="volume" tagx="volume" title="volume">46</span><span class="issue" tagx="issue" title="issue">23</span><span class="fpage" tagx="fpage" title="fpage">5064</span><span class="lpage" tagx="lpage" title="lpage">5073</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/jm030932o">10.1021/jm030932o</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/14584956">14584956</a></span></span></li> <li tag="ref"><a name="B9" /><span class="label" tagx="label" title="label">9</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bendich</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Clements</span><span class="given-names" tagx="given-names" title="given-names">G. C.</span></span></span><span class="mixed-article-title" title="mixed-article-title">A revision of the structural formulation of vicine and its pyrimidine aglucone, divicine</span><span class="source" tagx="source" title="source"><i>Biochimica et Biophysica Acta</i></span><span class="year" tagx="year" title="year">1953</span><span class="volume" tagx="volume" title="volume">12</span><span class="issue" tagx="issue" title="issue">1-2</span><span class="fpage" tagx="fpage" title="fpage">462</span><span class="lpage" tagx="lpage" title="lpage">477</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/0006-3002(53)90166-8">10.1016/0006-3002(53)90166-8</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/13115456">13115456</a></span></span></li> <li tag="ref"><a name="B10" /><span class="label" tagx="label" title="label">10</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hamed</span><span class="given-names" tagx="given-names" title="given-names">A. N. E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Schmitz</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bergermann</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Bioactive pyrrole alkaloids isolated from the Red Sea: marine sponge Stylissa carteri</span><span class="source" tagx="source" title="source"><i>Zeitschrift fÃ¼r Naturforschung</i></span><span class="year" tagx="year" title="year">2018</span><span class="volume" tagx="volume" title="volume">73</span><span class="issue" tagx="issue" title="issue">5-6</span><span class="fpage" tagx="fpage" title="fpage">199</span><span class="lpage" tagx="lpage" title="lpage">210</span><span class="pub-id"><a href="https://dx.doi.org/10.1515/znc-2017-0161">10.1515/znc-2017-0161</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29353267">29353267</a></span></span></li> <li tag="ref"><a name="B11" /><span class="label" tagx="label" title="label">11</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Assmann</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Van Soest</span><span class="given-names" tagx="given-names" title="given-names">R. W. M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kock</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">New antifeedant bromopyrrole alkaloid from the Caribbean sponge <i>Stylissa caribica</i></span><span class="source" tagx="source" title="source"><i>Journal of Natural Products</i></span><span class="year" tagx="year" title="year">2001</span><span class="volume" tagx="volume" title="volume">64</span><span class="issue" tagx="issue" title="issue">10</span><span class="fpage" tagx="fpage" title="fpage">1345</span><span class="lpage" tagx="lpage" title="lpage">1347</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/np000482s">10.1021/np000482s</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11678664">11678664</a></span></span></li> <li tag="ref"><a name="B12" /><span class="label" tagx="label" title="label">12</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Karlberg</span><span class="given-names" tagx="given-names" title="given-names">B. E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lins</span><span class="given-names" tagx="given-names" title="given-names">L. E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hermansson</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension</span><span class="source" tagx="source" title="source"><i>Journal of Hypertension</i></span><span class="year" tagx="year" title="year">1999</span><span class="volume" tagx="volume" title="volume">17</span><span class="issue" tagx="issue" title="issue">2</span><span class="fpage" tagx="fpage" title="fpage">293</span><span class="lpage" tagx="lpage" title="lpage">302</span><span class="pub-id"><a href="https://dx.doi.org/10.1097/00004872-199917020-00015">10.1097/00004872-199917020-00015</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10067800">10067800</a></span></span></li> <li tag="ref"><a name="B13" /><span class="label" tagx="label" title="label">13</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rushworth</span><span class="given-names" tagx="given-names" title="given-names">G. F.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Megson</span><span class="given-names" tagx="given-names" title="given-names">I. L.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits</span><span class="source" tagx="source" title="source"><i>Pharmacology &amp;amp; Therapeutics</i></span><span class="year" tagx="year" title="year">2014</span><span class="volume" tagx="volume" title="volume">141</span><span class="issue" tagx="issue" title="issue">2</span><span class="fpage" tagx="fpage" title="fpage">150</span><span class="lpage" tagx="lpage" title="lpage">159</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.pharmthera.2013.09.006">10.1016/j.pharmthera.2013.09.006</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24080471">24080471</a></span></span></li> <li tag="ref"><a name="B14" /><span class="label" tagx="label" title="label">14</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ni</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jiang</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kutyreff</span><span class="given-names" tagx="given-names" title="given-names">C. J.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Molybdenum-based nanoclusters act as antioxidants and ameliorate acute kidney injury in mice</span><span class="source" tagx="source" title="source"><i>Nature Communications</i></span><span class="year" tagx="year" title="year">2018</span><span class="volume" tagx="volume" title="volume">9</span><span class="issue" tagx="issue" title="issue">1</span><span class="fpage" tagx="fpage" title="fpage">5421</span><span class="lpage" tagx="lpage" title="lpage">5432</span><span class="pub-id"><a href="https://dx.doi.org/10.1038/s41467-018-07890-8">10.1038/s41467-018-07890-8</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30575745">30575745</a></span></span></li> <li tag="ref"><a name="B15" /><span class="label" tagx="label" title="label">15</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Okusa</span><span class="given-names" tagx="given-names" title="given-names">M. D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rosner</span><span class="given-names" tagx="given-names" title="given-names">M. H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kellum</span><span class="given-names" tagx="given-names" title="given-names">J. A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ronco</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Acute Dialysis Quality Initiative XIII Workgroup</span></span></span><span class="mixed-article-title" title="mixed-article-title">Therapeutic targets of human AKI: harmonizing human and animal AKI</span><span class="source" tagx="source" title="source"><i>Journals of the American Society of Nephrology</i></span><span class="year" tagx="year" title="year">2016</span><span class="volume" tagx="volume" title="volume">27</span><span class="issue" tagx="issue" title="issue">1</span><span class="fpage" tagx="fpage" title="fpage">44</span><span class="lpage" tagx="lpage" title="lpage">48</span><span class="pub-id"><a href="https://dx.doi.org/10.1681/asn.2015030233">10.1681/asn.2015030233</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26519086">26519086</a></span></span></li> <li tag="ref"><a name="B16" /><span class="label" tagx="label" title="label">16</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Pannu</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Manns</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tonelli</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Systematic review of the impact of N-acetylcysteine on contrast nephropathy</span><span class="source" tagx="source" title="source"><i>Kidney International</i></span><span class="year" tagx="year" title="year">2004</span><span class="volume" tagx="volume" title="volume">65</span><span class="issue" tagx="issue" title="issue">4</span><span class="fpage" tagx="fpage" title="fpage">1366</span><span class="lpage" tagx="lpage" title="lpage">1374</span><span class="pub-id"><a href="https://dx.doi.org/10.1111/j.1523-1755.2004.00516.x">10.1111/j.1523-1755.2004.00516.x</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15086476">15086476</a></span></span></li> <li tag="ref"><a name="B17" /><span class="label" tagx="label" title="label">17</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xiao</span><span class="given-names" tagx="given-names" title="given-names">B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xiang</span><span class="given-names" tagx="given-names" title="given-names">F.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases</span><span class="source" tagx="source" title="source"><i>Nature Communications</i></span><span class="year" tagx="year" title="year">2020</span><span class="volume" tagx="volume" title="volume">11</span><span class="issue" tagx="issue" title="issue">1</span><span class="fpage" tagx="fpage" title="fpage">2788</span><span class="lpage" tagx="lpage" title="lpage">2804</span><span class="pub-id"><a href="https://dx.doi.org/10.1038/s41467-020-16544-7">10.1038/s41467-020-16544-7</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/32493916">32493916</a></span></span></li> <li tag="ref"><a name="B18" /><span class="label" tagx="label" title="label">18</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Armstrong</span><span class="given-names" tagx="given-names" title="given-names">N.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ramamoorthy</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lyon</span><span class="given-names" tagx="given-names" title="given-names">D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jones</span><span class="given-names" tagx="given-names" title="given-names">K.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Duttaroy</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Mechanism of silver nanoparticles action on insect pigmentation reveals intervention of copper homeostasis</span><span class="source" tagx="source" title="source"><i>PLoS ONE</i></span><span class="year" tagx="year" title="year">2013</span><span class="volume" tagx="volume" title="volume">8</span><span class="issue" tagx="issue" title="issue">1</span><span class="fpage" tagx="fpage" title="fpage">p. e53186</span><span class="pub-id"><a href="https://dx.doi.org/10.1371/journal.pone.0053186">10.1371/journal.pone.0053186</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23308159">23308159</a></span></span></li> <li tag="ref"><a name="B19" /><span class="label" tagx="label" title="label">19</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kotynia</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Janek</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">CzyÅ¼nikowska</span><span class="given-names" tagx="given-names" title="given-names">Å».</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">BieliÅ"ska</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kamysz</span><span class="given-names" tagx="given-names" title="given-names">W.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">BrasuÅ"</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span></span><span class="mixed-article-title" title="mixed-article-title">The analysis of Cu(II)/Zn(II) cyclopeptide system as potential Cu,ZnSOD mimic center</span><span class="source" tagx="source" title="source"><i>International Journal of Peptide Research and Therapeutics</i></span><span class="year" tagx="year" title="year">2017</span><span class="volume" tagx="volume" title="volume">23</span><span class="issue" tagx="issue" title="issue">4</span><span class="fpage" tagx="fpage" title="fpage">431</span><span class="lpage" tagx="lpage" title="lpage">439</span><span class="pub-id"><a href="https://dx.doi.org/10.1007/s10989-017-9574-8">10.1007/s10989-017-9574-8</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29170621">29170621</a></span></span></li> <li tag="ref"><a name="B20" /><span class="label" tagx="label" title="label">20</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Solomon</span><span class="given-names" tagx="given-names" title="given-names">E. I.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lowery</span><span class="given-names" tagx="given-names" title="given-names">M. D.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Electronic structure contributions to function in bioinorganic chemistry</span><span class="source" tagx="source" title="source"><i>Science</i></span><span class="year" tagx="year" title="year">1993</span><span class="volume" tagx="volume" title="volume">259</span><span class="issue" tagx="issue" title="issue">5101</span><span class="fpage" tagx="fpage" title="fpage">1575</span><span class="lpage" tagx="lpage" title="lpage">1581</span><span class="pub-id"><a href="https://dx.doi.org/10.1126/science.8384374">10.1126/science.8384374</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/8384374">8384374</a></span></span></li> <li tag="ref"><a name="B21" /><span class="label" tagx="label" title="label">21</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cass</span><span class="given-names" tagx="given-names" title="given-names">A. E.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hill</span><span class="given-names" tagx="given-names" title="given-names">H. A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Copper proteins and copper enzymes</span><span class="source" tagx="source" title="source"><i>Ciba Foundation Symposium</i></span><span class="year" tagx="year" title="year">2008</span><span class="volume" tagx="volume" title="volume">79</span><span class="fpage" tagx="fpage" title="fpage">71</span><span class="lpage" tagx="lpage" title="lpage">91</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/9780470720622.ch5">10.1002/9780470720622.ch5</a></span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/6907091">6907091</a></span></span></li> <li tag="ref"><a name="B22" /><span class="label" tagx="label" title="label">22</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yuan</span><span class="given-names" tagx="given-names" title="given-names">Y.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Majeed</span><span class="given-names" tagx="given-names" title="given-names">S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Copper nanoclusters as peroxidase mimetics and their applications to H<sub>2</sub>O<sub>2</sub> and glucose detection</span><span class="source" tagx="source" title="source"><i>Analytica Chimica Acta</i></span><span class="year" tagx="year" title="year">2013</span><span class="volume" tagx="volume" title="volume">762</span><span class="fpage" tagx="fpage" title="fpage">83</span><span class="lpage" tagx="lpage" title="lpage">86</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.aca.2012.11.056">10.1016/j.aca.2012.11.056</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23327949">23327949</a></span></span></li> <li tag="ref"><a name="B23" /><span class="label" tagx="label" title="label">23</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">W. C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lyu</span><span class="given-names" tagx="given-names" title="given-names">L. M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">Y. C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">M. H.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis of Cu<sub>2</sub>O nanocrystals from cubic to rhombic dodecahedral structures and their comparative photocatalytic activity</span><span class="source" tagx="source" title="source"><i>Journal of the American Chemical Society</i></span><span class="year" tagx="year" title="year">2011</span><span class="volume" tagx="volume" title="volume">134</span><span class="issue" tagx="issue" title="issue">2</span><span class="fpage" tagx="fpage" title="fpage">1261</span><span class="lpage" tagx="lpage" title="lpage">1267</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/ja209662v">10.1021/ja209662v</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22257266">22257266</a></span></span></li> <li tag="ref"><a name="B24" /><span class="label" tagx="label" title="label">24</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sheng</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chen</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kang</span><span class="given-names" tagx="given-names" title="given-names">J.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Octahedral Cu<sub>2</sub>O@Co(OH)<sub>2</sub> nanocages with hierarchical Flakeâ€�Like walls and yolk-shell structures for enhanced electrocatalytic activity</span><span class="source" tagx="source" title="source"><i>ChemCatChem</i></span><span class="year" tagx="year" title="year">2019</span><span class="volume" tagx="volume" title="volume">11</span><span class="issue" tagx="issue" title="issue">10</span><span class="fpage" tagx="fpage" title="fpage">2520</span><span class="lpage" tagx="lpage" title="lpage">2525</span><span class="pub-id"><a href="https://dx.doi.org/10.1002/cctc.201900036">10.1002/cctc.201900036</a></span><span class="pub-id" /></span></li> <li tag="ref"><a name="B25" /><span class="label" tagx="label" title="label">25</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">C. L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Weng</span><span class="given-names" tagx="given-names" title="given-names">W. L.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">Y. S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liao</span><span class="given-names" tagx="given-names" title="given-names">C. N.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Enhanced photolysis stability of Cu<sub>2</sub>O grown on cu nanowires with nanoscale twin boundaries</span><span class="source" tagx="source" title="source"><i>Nanoscale</i></span><span class="year" tagx="year" title="year">2019</span><span class="volume" tagx="volume" title="volume">11</span><span class="issue" tagx="issue" title="issue">29</span><span class="fpage" tagx="fpage" title="fpage">13709</span><span class="lpage" tagx="lpage" title="lpage">13713</span><span class="pub-id"><a href="https://dx.doi.org/10.1039/C9NR01406C">10.1039/C9NR01406C</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31194206">31194206</a></span></span></li> <li tag="ref"><a name="B26" /><span class="label" tagx="label" title="label">26</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gawande</span><span class="given-names" tagx="given-names" title="given-names">M. B.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Goswami</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Felpin</span><span class="given-names" tagx="given-names" title="given-names">F. X.</span></span><span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Cu and cu-based nanoparticles: synthesis and applications in catalysis</span><span class="source" tagx="source" title="source"><i>Chemical Reviews</i></span><span class="year" tagx="year" title="year">2016</span><span class="volume" tagx="volume" title="volume">116</span><span class="issue" tagx="issue" title="issue">6</span><span class="fpage" tagx="fpage" title="fpage">3722</span><span class="lpage" tagx="lpage" title="lpage">3811</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/acs.chemrev.5b00482">10.1021/acs.chemrev.5b00482</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26935812">26935812</a></span></span></li> <li tag="ref"><a name="B27" /><span class="label" tagx="label" title="label">27</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Surendra Kumar</span><span class="given-names" tagx="given-names" title="given-names">R.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Moydeen</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Al-Deyab</span><span class="given-names" tagx="given-names" title="given-names">S. S.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Aseer</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Idhayadhulla</span><span class="given-names" tagx="given-names" title="given-names">A.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis of new morpholine - connected pyrazolidine derivatives and their antimicrobial, antioxidant, and cytotoxic activities</span><span class="source" tagx="source" title="source"><i>Bioorganic &amp;amp; Medicinal Chemistry Letters</i></span><span class="year" tagx="year" title="year">2017</span><span class="volume" tagx="volume" title="volume">27</span><span class="issue" tagx="issue" title="issue">1</span><span class="fpage" tagx="fpage" title="fpage">66</span><span class="lpage" tagx="lpage" title="lpage">71</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.bmcl.2016.11.032">10.1016/j.bmcl.2016.11.032</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27889456">27889456</a></span></span></li> <li tag="ref"><a name="B28" /><span class="label" tagx="label" title="label">28</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">LiÃ©geois</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lermusieau</span><span class="given-names" tagx="given-names" title="given-names">G.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Collin</span><span class="given-names" tagx="given-names" title="given-names">C.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Measuring Antioxidant Efficiency of Wort, Malt, and Hops against the 2,2â€˜-Azobis(2-amidinopropane) Dihydrochloride-Induced Oxidation of an Aqueous Dispersion of Linoleic Acid</span><span class="source" tagx="source" title="source"><i>Journal of Agricultural and Food Chemistry</i></span><span class="year" tagx="year" title="year">2000</span><span class="volume" tagx="volume" title="volume">48</span><span class="issue" tagx="issue" title="issue">4</span><span class="fpage" tagx="fpage" title="fpage">1129</span><span class="lpage" tagx="lpage" title="lpage">1134</span><span class="pub-id"><a href="https://dx.doi.org/10.1021/jf9911242">10.1021/jf9911242</a></span><span class="pub-id" /><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10775361">10775361</a></span></span></li> <li tag="ref"><a name="B29" /><span class="label" tagx="label" title="label">29</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Scudiero</span><span class="given-names" tagx="given-names" title="given-names">A. D.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shoemaker</span><span class="given-names" tagx="given-names" title="given-names">R. H.</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Paull</span><span class="given-names" tagx="given-names" title="given-names">K. D.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines</span><span class="source" tagx="source" title="source"><i>Cancer Research</i></span><span class="year" tagx="year" title="year">1988</span><span class="volume" tagx="volume" title="volume">48</span><span class="issue" tagx="issue" title="issue">17</span><span class="fpage" tagx="fpage" title="fpage">4827</span><span class="lpage" tagx="lpage" title="lpage">4833</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/3409223">3409223</a></span></span></li> </ul> </div> </div> <div class="floats-group" title="floats-group"> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 1</span></a></div>   <p>Biologically active natural pyrimidinamine compounds.</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 2</span></a></div>   <p>Structure of telmisartan.</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Scheme 1</span></a></div>   <p>Synthetic route of 2-pyrimidinamine derivatives.</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 3</span></a></div>   <p>FT-IR spectrum for telmisartan-mediated copper nanoparticle.</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 4</span></a></div>   <p>UV-vis spectra of Cu-Nps.</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 5</span></a></div>   <p>Telmisartan Cu-Nps of SEM images.</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 6</span></a></div>   <p>Telmisartan-copper nanoparticle of ED.</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 7</span></a></div>   <p>XRD studies of telmisartan-mediated copper nanoparticle.</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 8</span></a></div>   <p>(a) AFM image of Cu-Np catalyst. (b) The profile of Cu in telmisartan-mediated copper nanaoparicles. (c) The waviness of Cu-Nps. (d) The roughness of Cu-Nps.</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 9</span></a></div>   <p>TG/DTA curve of Cu-Np precursor.</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 10</span></a></div>   <p>Particle size analysis of Cu-Nps.</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 11</span></a></div>   <p>Recyclability of telmisartan copper nanoparticle catalyst.</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Scheme 2</span></a></div>   <p>Catalysis performance with mechanism of compound preparation <b>(</b>1a-1c).</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Scheme 3</span></a></div>   <p>Mechanism of expected product and unreacted unexpected copper nanoparticles connected 2-pyrimidine compounds.</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Scheme 4</span></a></div>   <p>ABTS<sup>Â·+</sup> radical scavengingâ€"mechanism of inhibition.</p>   </div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Scheme 5</span></a></div>   <p>Lipid peroxidationâ€"mechanism of inhibition.</p>   </div> <div class="table-wrap_UNKNOWN" id="tab1" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 1</span> <p>Antioxidant activities of pyrimidinamine derivatives 1a-c, Cu-N, and Cu-N-Pyr.</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th align="left" rowspan="2" colspan="1">Compounds</th> <th align="center" colspan="2" rowspan="1">Percentage of activity (%)<sup>a</sup></th> </tr> <tr> <th align="center" rowspan="1" colspan="1">ABTS<sup>Â·<i>+</i></sup></th> <th align="center" rowspan="1" colspan="1">AAPH</th> </tr> </thead> <tbody> <tr> <td align="left" rowspan="1" colspan="1">1a</td> <td align="center" rowspan="1" colspan="1">54.3 Â± 0.07</td> <td align="center" rowspan="1" colspan="1">64.2 Â± 0.61</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">1b</td> <td align="center" rowspan="1" colspan="1">61.0 Â± 0.12</td> <td align="center" rowspan="1" colspan="1">72.0 Â± 0.11</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">1c</td> <td align="center" rowspan="1" colspan="1">80.8 Â± 0.12</td> <td align="center" rowspan="1" colspan="1">71.6 Â± 0.24</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">Cu-Nps</td> <td align="center" rowspan="1" colspan="1">28.3 Â± 0.10</td> <td align="center" rowspan="1" colspan="1">37.9 Â± 0.32</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">Cu-Nps â€"Pyr-1a</td> <td align="center" rowspan="1" colspan="1">72.1 Â± 0.23</td> <td align="center" rowspan="1" colspan="1">78.3 Â± 0.61</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">Cu-Nps â€"Pyr-1b</td> <td align="center" rowspan="1" colspan="1">86.3 Â± 0.13</td> <td align="center" rowspan="1" colspan="1">80.3 Â± 0.42</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">Cu-Nps â€"Pyr-1c</td> <td align="center" rowspan="1" colspan="1">97.2 Â± 0.20</td> <td align="center" rowspan="1" colspan="1">91.2 Â± 0.28</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">Trolox</td> <td align="center" rowspan="1" colspan="1">85.2 Â± 0.09</td> <td align="center" rowspan="1" colspan="1">62.3 Â± 0.28</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p><sup>a</sup>Values are the meansofthreereplicates Â± SD.</p> </div> </div> </div> <div class="table-wrap_UNKNOWN" id="tab2" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 2</span> <p>EDX analysis of percentage of elements present in Cu-Nps.</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th align="left" rowspan="1" colspan="1">Element line</th> <th align="center" rowspan="1" colspan="1">Weight (%)</th> <th align="center" rowspan="1" colspan="1">Weight % error</th> <th align="center" rowspan="1" colspan="1">Atom (%)</th> </tr> </thead> <tbody> <tr> <td align="left" rowspan="1" colspan="1">C K</td> <td align="center" rowspan="1" colspan="1">74.54</td> <td align="center" rowspan="1" colspan="1">Â±3.03</td> <td align="center" rowspan="1" colspan="1">82.93</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">O K</td> <td align="center" rowspan="1" colspan="1">18.75</td> <td align="center" rowspan="1" colspan="1">Â±2.92</td> <td align="center" rowspan="1" colspan="1">15.66</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">Cu K</td> <td align="center" rowspan="1" colspan="1">6.72</td> <td align="center" rowspan="1" colspan="1">Â±3.54</td> <td align="center" rowspan="1" colspan="1">1.41</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">Cu L</td> <td align="center" rowspan="1" colspan="1">â€"</td> <td align="center" rowspan="1" colspan="1">â€"</td> <td align="center" rowspan="1" colspan="1">â€"</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">Total</td> <td align="center" rowspan="1" colspan="1">100.00</td> <td rowspan="1" colspan="1" /> <td align="center" rowspan="1" colspan="1">100.00</td> </tr> </tbody> </table> </div> <div class="table-wrap_UNKNOWN" id="tab3" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 3</span> <p>Catalyst recyclability.</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th align="left" rowspan="1" colspan="1">Entry</th> <th align="center" rowspan="1" colspan="1">Catalyst use</th> <th align="center" rowspan="1" colspan="1">Yield (%)</th> </tr> </thead> <tbody> <tr> <td align="left" rowspan="1" colspan="1">1</td> <td align="center" rowspan="1" colspan="1">1<sup>st</sup></td> <td align="center" rowspan="1" colspan="1">88</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">2</td> <td align="center" rowspan="1" colspan="1">2<sup>nd</sup></td> <td align="center" rowspan="1" colspan="1">88</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">3</td> <td align="center" rowspan="1" colspan="1">3<sup>rd</sup></td> <td align="center" rowspan="1" colspan="1">88</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">4</td> <td align="center" rowspan="1" colspan="1">4<sup>th</sup></td> <td align="center" rowspan="1" colspan="1">88</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">5</td> <td align="center" rowspan="1" colspan="1">5<sup>th</sup></td> <td align="center" rowspan="1" colspan="1">88</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">6</td> <td align="center" rowspan="1" colspan="1">6<sup>th</sup></td> <td align="center" rowspan="1" colspan="1">87</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">7</td> <td align="center" rowspan="1" colspan="1">7<sup>th</sup></td> <td align="center" rowspan="1" colspan="1">87</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">8</td> <td align="center" rowspan="1" colspan="1">8<sup>th</sup></td> <td align="center" rowspan="1" colspan="1">86</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">9</td> <td align="center" rowspan="1" colspan="1">9<sup>th</sup></td> <td align="center" rowspan="1" colspan="1">86</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">10</td> <td align="center" rowspan="1" colspan="1">10<sup>th</sup></td> <td align="center" rowspan="1" colspan="1">85</td> </tr> </tbody> </table> </div> <div class="table-wrap_UNKNOWN" id="tab4" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 4</span> <p>Optimization of reaction condition.</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th align="left" rowspan="1" colspan="1">S. no.</th> <th align="center" rowspan="1" colspan="1">R</th> <th align="center" rowspan="1" colspan="1">Ar</th> <th align="center" rowspan="1" colspan="1">Reaction condition</th> <th align="center" rowspan="1" colspan="1">Catalyst mole (%)</th> <th align="center" rowspan="1" colspan="1">Yield (%)</th> <th align="center" rowspan="1" colspan="1">Final product structure</th> </tr> </thead> <tbody> <tr> <td align="left" rowspan="1" colspan="1">1a</td> <td align="center" rowspan="1" colspan="1">-NH<sub>2</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">10â€‰min, RT</td> <td align="center" rowspan="1" colspan="1">1.0</td> <td align="center" rowspan="1" colspan="1">88</td> <td align="center" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> </tr> <tr> <td align="left" rowspan="1" colspan="1">1b</td> <td align="center" rowspan="1" colspan="1">-NH-Ph</td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">10â€‰min, RT</td> <td align="center" rowspan="1" colspan="1">1.0</td> <td align="center" rowspan="1" colspan="1">88</td> <td align="center" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> </tr> <tr> <td align="left" rowspan="1" colspan="1">1c</td> <td align="center" rowspan="1" colspan="1">-CS-NH<sub>2</sub></td> <td align="center" rowspan="1" colspan="1">Ph</td> <td align="center" rowspan="1" colspan="1">10â€‰min, RT</td> <td align="center" rowspan="1" colspan="1">1.0</td> <td align="center" rowspan="1" colspan="1">88</td> <td align="center" rowspan="1" colspan="1"><span class="inline-graphic" title="inline-graphic" /></td> </tr> </tbody> </table> </div> <div class="table-wrap_UNKNOWN" id="tab5" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 5</span> <p>Optimization of catalyst of Cu-Nps.</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th align="left" rowspan="1" colspan="1">S. No.</th> <th align="center" rowspan="1" colspan="1">Catalyst</th> <th align="center" rowspan="1" colspan="1">Mole (%)</th> <th align="center" rowspan="1" colspan="1">Yield (%)</th> <th align="center" rowspan="1" colspan="1">Yield (%) of Cu-N-Pyr</th> </tr> </thead> <tbody> <tr> <td align="left" rowspan="1" colspan="1">1</td> <td align="center" rowspan="1" colspan="1">Telmisartan</td> <td align="center" rowspan="1" colspan="1">1</td> <td align="center" rowspan="1" colspan="1">56</td> <td align="center" rowspan="1" colspan="1">0</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">2</td> <td align="center" rowspan="1" colspan="1">Cu-Nps</td> <td align="center" rowspan="1" colspan="1">5</td> <td align="center" rowspan="1" colspan="1">94</td> <td align="center" rowspan="1" colspan="1">0.6</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">3</td> <td align="center" rowspan="1" colspan="1">Cu-Nps</td> <td align="center" rowspan="1" colspan="1">4</td> <td align="center" rowspan="1" colspan="1">92</td> <td align="center" rowspan="1" colspan="1">0.8</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">4</td> <td align="center" rowspan="1" colspan="1">Cu-Nps</td> <td align="center" rowspan="1" colspan="1">3</td> <td align="center" rowspan="1" colspan="1">90</td> <td align="center" rowspan="1" colspan="1">10</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">5</td> <td align="center" rowspan="1" colspan="1">Cu-Nps</td> <td align="center" rowspan="1" colspan="1">2</td> <td align="center" rowspan="1" colspan="1">89</td> <td align="center" rowspan="1" colspan="1">11</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">6</td> <td align="center" rowspan="1" colspan="1">Cu-Nps</td> <td align="center" rowspan="1" colspan="1">1</td> <td align="center" rowspan="1" colspan="1">88</td> <td align="center" rowspan="1" colspan="1">12</td> </tr> </tbody> </table> </div> <div class="table-wrap_UNKNOWN" id="tab6" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 6</span> <p>Cytotoxic activities of pyrimidinamine derivatives 1a-c, Cu-N, and Cu-N-Pyr.</p>  <table frame="hsides" rules="groups"> <thead> <tr> <th align="left" rowspan="2" colspan="1">Compounds</th> <th align="center" colspan="3" rowspan="1">HepG2</th> <th align="center" colspan="3" rowspan="1">MCF-7</th> <th align="center" colspan="3" rowspan="1">HeLa</th> </tr> <tr> <th align="center" rowspan="1" colspan="1">GI<sub>50</sub> (<i>Î¼</i>M)</th> <th align="center" rowspan="1" colspan="1">TGI (<i>Î¼</i>M)</th> <th align="center" rowspan="1" colspan="1">LC<sub>50</sub> (<i>Î¼</i>M)</th> <th align="center" rowspan="1" colspan="1">GI<sub>50</sub> (<i>Î¼</i>M)</th> <th align="center" rowspan="1" colspan="1">TGI (<i>Î¼</i>M)</th> <th align="center" rowspan="1" colspan="1">LC<sub>50</sub> (<i>Î¼</i>M)</th> <th align="center" rowspan="1" colspan="1">GI<sub>50</sub> (<i>Î¼</i>M)</th> <th align="center" rowspan="1" colspan="1">TGI (<i>Î¼</i>M)</th> <th align="center" rowspan="1" colspan="1">LC<sub>50</sub> (<i>Î¼</i>M)</th> </tr> </thead> <tbody> <tr> <td align="left" rowspan="1" colspan="1">1a</td> <td align="center" rowspan="1" colspan="1">03.2</td> <td align="center" rowspan="1" colspan="1">09.3</td> <td align="center" rowspan="1" colspan="1">32.1</td> <td align="center" rowspan="1" colspan="1">0.06</td> <td align="center" rowspan="1" colspan="1">0.62</td> <td align="center" rowspan="1" colspan="1">12.0</td> <td align="center" rowspan="1" colspan="1">0.69</td> <td align="center" rowspan="1" colspan="1">12.3</td> <td align="center" rowspan="1" colspan="1">25.6</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">1b</td> <td align="center" rowspan="1" colspan="1">02.1</td> <td align="center" rowspan="1" colspan="1">06.1</td> <td align="center" rowspan="1" colspan="1">24.1</td> <td align="center" rowspan="1" colspan="1">12.2</td> <td align="center" rowspan="1" colspan="1">24.3</td> <td align="center" rowspan="1" colspan="1">42.2</td> <td align="center" rowspan="1" colspan="1">0.09</td> <td align="center" rowspan="1" colspan="1">20.3</td> <td align="center" rowspan="1" colspan="1">41.2</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">1c</td> <td align="center" rowspan="1" colspan="1">06.3</td> <td align="center" rowspan="1" colspan="1">14.3</td> <td align="center" rowspan="1" colspan="1">44.1</td> <td align="center" rowspan="1" colspan="1">10.2</td> <td align="center" rowspan="1" colspan="1">20.3</td> <td align="center" rowspan="1" colspan="1">41.3</td> <td align="center" rowspan="1" colspan="1">12.3</td> <td align="center" rowspan="1" colspan="1">24.6</td> <td align="center" rowspan="1" colspan="1">46.2</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">Cu-Nps</td> <td align="center" rowspan="1" colspan="1">12.3</td> <td align="center" rowspan="1" colspan="1">24.2</td> <td align="center" rowspan="1" colspan="1">45.3</td> <td align="center" rowspan="1" colspan="1">18.5</td> <td align="center" rowspan="1" colspan="1">36.2</td> <td align="center" rowspan="1" colspan="1">69.6</td> <td align="center" rowspan="1" colspan="1">21.0</td> <td align="center" rowspan="1" colspan="1">46.3</td> <td align="center" rowspan="1" colspan="1">84.0</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">Cu-Nps-Pyr-1a</td> <td align="center" rowspan="1" colspan="1">0.02</td> <td align="center" rowspan="1" colspan="1">0.21</td> <td align="center" rowspan="1" colspan="1">0.59</td> <td align="center" rowspan="1" colspan="1">0.04</td> <td align="center" rowspan="1" colspan="1">0.28</td> <td align="center" rowspan="1" colspan="1">0.81</td> <td align="center" rowspan="1" colspan="1">0.01</td> <td align="center" rowspan="1" colspan="1">0.19</td> <td align="center" rowspan="1" colspan="1">0.42</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">Cu-Nps-Pyr-1b</td> <td align="center" rowspan="1" colspan="1">0.01</td> <td align="center" rowspan="1" colspan="1">06.1</td> <td align="center" rowspan="1" colspan="1">24.1</td> <td align="center" rowspan="1" colspan="1">12.2</td> <td align="center" rowspan="1" colspan="1">24.3</td> <td align="center" rowspan="1" colspan="1">42.2</td> <td align="center" rowspan="1" colspan="1">0.12</td> <td align="center" rowspan="1" colspan="1">0.33</td> <td align="center" rowspan="1" colspan="1">0.92</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">Cu-Nps-Pyr-1c</td> <td align="center" rowspan="1" colspan="1">0.05</td> <td align="center" rowspan="1" colspan="1">14.3</td> <td align="center" rowspan="1" colspan="1">44.1</td> <td align="center" rowspan="1" colspan="1">0.02</td> <td align="center" rowspan="1" colspan="1">0.13</td> <td align="center" rowspan="1" colspan="1">0.53</td> <td align="center" rowspan="1" colspan="1">0.05</td> <td align="center" rowspan="1" colspan="1">0.16</td> <td align="center" rowspan="1" colspan="1">0.36</td> </tr> <tr> <td align="left" rowspan="1" colspan="1">Doxorubicin</td> <td align="center" rowspan="1" colspan="1">0.01</td> <td align="center" rowspan="1" colspan="1">0.13</td> <td align="center" rowspan="1" colspan="1">0.58</td> <td align="center" rowspan="1" colspan="1">0.02</td> <td align="center" rowspan="1" colspan="1">0.21</td> <td align="center" rowspan="1" colspan="1">0.74</td> <td align="center" rowspan="1" colspan="1">0.05</td> <td align="center" rowspan="1" colspan="1">0.41</td> <td align="center" rowspan="1" colspan="1">0.88</td> </tr> </tbody> </table> </div> </div>  </body></html>